(Q36019390)

11 August 2017

1 reference

title

Rationale for the development and current status of calcitriol in androgen-independent prostate cancer (English)

1 reference

11 August 2017

1 reference

1

Tomasz M Beer

1 reference

11 August 2017

Anne Myrthue

2

1 reference

11 August 2017

Kristine M Eilers

series ordinal

3

1 reference

11 August 2017

publication date

25 January 2005

1 reference

11 August 2017

published in

World Journal of Urology

1 reference

11 August 2017

volume

23

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

28-32

1 reference

Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery

11 August 2017

cites work

1 reference

12 December 2020

Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.

1 reference

12 December 2020

IGF-binding proteins in human prostate tumor cells: expression and regulation by 1,25-dihydroxyvitamin D3.

1 reference

12 December 2020

Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer

1 reference

12 December 2020

Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues

1 reference

12 December 2020

1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells

1 reference

12 December 2020

Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin

1 reference

12 December 2020

Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling.

1 reference

12 December 2020

Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines.

1 reference

12 December 2020

Vitamin D3 is a potent inhibitor of tumor cell-induced angiogenesis

1 reference

12 December 2020

Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone

1 reference

12 December 2020

Apoptosis induction by 1alpha,25-dihydroxyvitamin D3 in prostate cancer.

1 reference

12 December 2020

Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells

1 reference

12 December 2020

1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines

1 reference

12 December 2020

1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells

1 reference

12 December 2020

High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma

1 reference

12 December 2020

1,25-Dihydroxyvitamin D3 suppresses cell growth, DNA synthesis, and phosphorylation of retinoblastoma protein in a breast cancer cell line

1 reference

12 December 2020

Docetaxel (Taxotere) as monotherapy in the treatment of hormone-refractory prostate cancer: preliminary results

1 reference

12 December 2020

Vitamin D: A millenium perspective

1 reference

12 December 2020

Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells

1 reference

12 December 2020

Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines

1 reference

12 December 2020

Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.

1 reference

12 December 2020

Late dephosphorylation of the RB protein in G2 during the process of induced cell differentiation

1 reference

12 December 2020

Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate

1 reference

12 December 2020

Toward therapeutic intervention of cancer by vitamin D compounds

1 reference

12 December 2020

Molecular pathways involved in the antineoplastic effects of calcitriol on insulinoma cells

1 reference

12 December 2020

Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines

1 reference

12 December 2020

The nuclear receptor superfamily: the second decade

1 reference

12 December 2020

Calcitriol (1,25-dihydroxycholecalciferol) potentiates activity of mitoxantrone/dexamethasone in an androgen independent prostate cancer model

1 reference

12 December 2020

1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration

1 reference

12 December 2020

p53 Is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cells

1 reference

12 December 2020

Growth inhibition of human keratinocytes by 1,25-dihydroxyvitamin D3 is linked to dephosphorylation of retinoblastoma gene product

1 reference

12 December 2020

Weekly high-dose calcitriol and docetaxel in advanced prostate cancer

1 reference

12 December 2020

1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo

1 reference

12 December 2020

Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter

1 reference

12 December 2020

Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation

1 reference

12 December 2020

Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol)

1 reference

12 December 2020

A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy

1 reference

12 December 2020

1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo

1 reference

12 December 2020

Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer

1 reference

12 December 2020

Vitamin D in preventive medicine: are we ignoring the evidence?

1 reference

12 December 2020

Human prostate cancer cells: inhibition of proliferation by vitamin D analogs.

1 reference

12 December 2020

Vitamin D receptor expression is required for growth modulation by 1 alpha,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31.

1 reference

12 December 2020

Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.

1 reference

12 December 2020

The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro

1 reference

12 December 2020

Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer

1 reference

12 December 2020

A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: correlation of antitumor effect to phosphorylation of Bcl-2

1 reference

12 December 2020

Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3

1 reference

12 December 2020

A Phase I trial of pulse calcitriol in patients with refractory malignancies: pulse dosing permits substantial dose escalation

1 reference

12 December 2020

Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells

1 reference

12 December 2020

Antiproliferative effects of 1alpha,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells

1 reference

12 December 2020

Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system

1 reference

12 December 2020

Pharmacokinetics of high-dose oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel

1 reference

12 December 2020

10.1007/S00345-004-0476-Y

Identifiers

DOI

1 reference

release_2agth7ajwbe2zau4ikob3pyn24

11 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2agth7ajwbe2zau4ikob3pyn24

24 November 2022

mapped directly with Wikidata item

1 reference